The Evaluation of Immunogenicity and Safety of NBP608 in Healthy Children 12 Months to 12 Years of Age
Condition: Varicella Interventions: Biological: NBP608; Biological: Varivax Sponsor: SK Chemicals Co.,Ltd. Completed - verified April 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials